|
KMID : 0043320160390121726
|
|
Archives of Pharmacal Research
2016 Volume.39 No. 12 p.1726 ~ p.1738
|
|
|
Anti-septic effects of pelargonidin on HMGB1-induced responses in vitro and in vivo
|
|
Min Ga-Hee
Ku Sae-Kwang
Park Mi-Seon
Park Tae-Joo
Lee Hyun-Shik
Bae Jong-Sup
|
|
|
Abstract
|
|
|
|
A certain nucleosomal protein?high mobility group box-1 (HMGB1)?has recently been established as a late mediator of sepsis, with a relatively wide therapeutic window for pharmacological intervention. Pelargonidin (PEL) is a well-known red pigment found in plants; it has important biological activities that are potentially beneficial for human health. In the present study, we investigated whether PEL can modulate HMGB1-mediated inflammatory responses in human umbilical vein endothelial cells (HUVECs) and in mice. The anti-inflammatory activities of PEL were determined by measuring permeability, leukocyte adhesion and migration, and activation of pro-inflammatory proteins in HMGB1-activated HUVECs and mice, as well as the beneficial effects of PEL on survival rate in the mouse sepsis model. The data showed that PEL had effectively inhibited lipopolysaccharide (LPS)-induced release of HMGB1 and suppressed HMGB1-mediated septic responses, such as hyperpermeability, adhesion and migration of leukocytes, and expression of cell adhesion molecules. Furthermore, PEL inhibited the HMGB1-mediated production of tumor necrosis factor alpha (TNF-α) and interleukin 6 (IL-6), as well as the activation of nuclear factor-κB (NF-κB) and extracellular signal-regulated kinases 1 and 2 (ERK1/2). Collectively, these results indicate that PEL could be used to treat various severe vascular inflammatory diseases via the inhibition of the HMGB1 signaling pathway.
|
|
|
KEYWORD
|
|
|
Pelargonidin, HMGB1, Sepsis, Inflammation, HUVEC
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|